Leveljump Forms New Tech Subsidiary Focused On Disrupting Healthcare Sector
Leveljump Healthcare Corp (TSXV: JUMP) this morning announced the forming of a new subsidiary. The subsidiary, referred to as Leveljump Technologies, will look to acquire or develop innovative products and services within the healthcare sector.
More specifically, the new subsidiary will have what the company refers to as “a mandate to primarily focus on new products and services that may have the potential to disrupt various segments of the healthcare industry.” This focus can reportedly take the form of direct investment in such tech, or the acquisition of related assets.
The subsidiary will also look to develop in-house solutions as they relate to the healthcare-tech sector.
The company identified a number of areas of interest in connection with the forming of the new subsidiary. Such areas include medical and diagnostic imaging, telehealth innovations, and eye care products and services.
“LJT will offer new innovations in healthcare procedures and products that can provide better patient care and reduce the cost pressure on the overstressed Canadian healthcare system.”
Mitchell Geisler, CEO of Leveljump
Leveljump Healthcare last traded at $0.38 on the TSX Venture.
FULL DISCLOSURE: Leveljump Healthcare Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Leveljump Healthcare Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
